Walgreens Return on Tangible Equity 2010-2024 | WBA

Current and historical return on tangible equity values for Walgreens (WBA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Walgreens Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-08-31 $-8.64B $-16.47B 60.23%
2024-05-31 $-5.81B $-13.40B 42.74%
2024-02-29 $-6.04B $-13.61B 45.08%
2023-11-30 $0.57B $-13.87B -4.35%
2023-08-31 $-3.08B $-13.50B 25.95%
2023-05-31 $-3.32B $-12.59B 35.25%
2023-02-28 $-3.14B $-12.77B 44.71%
2022-11-30 $-2.96B $-8.61B 63.06%
2022-08-31 $4.34B $-3.64B -124.81%
2022-05-31 $5.38B $-3.10B -244.77%
2022-02-28 $6.29B $-3.44B -417.67%
2021-11-30 $6.43B $-3.71B -658.14%
2021-08-31 $2.54B $1.46B -180.32%
2021-05-31 $2.29B $-0.33B -113.61%
2021-02-28 $-0.62B $-1.33B 21.44%
2020-11-30 $-0.70B $-5.44B 20.53%
2020-08-31 $0.46B $-0.95B -15.61%
2020-05-31 $0.76B $-3.81B -21.71%
2020-02-29 $3.49B $-3.38B -103.67%
2019-11-30 $3.70B $-3.54B -108.59%
2019-08-31 $3.98B $-3.28B -130.23%
2019-05-31 $4.82B $-3.27B -175.85%
2019-02-28 $5.13B $-3.55B -244.02%
2018-11-30 $5.33B $-2.13B -359.44%
2018-08-31 $5.02B $-2.01B -564.49%
2018-05-31 $4.31B $-0.73B 1847.54%
2018-02-28 $4.13B $-1.06B 222.74%
2017-11-30 $3.85B $0.24B 109.54%
2017-08-31 $4.08B $2.49B 87.87%
2017-05-31 $4.31B $5.76B 83.90%
2017-02-28 $4.25B $5.56B 92.20%
2016-11-30 $4.12B $4.76B 103.77%
2016-08-31 $4.17B $4.45B 119.00%
2016-05-31 $3.17B $3.66B 104.31%
2016-02-29 $3.37B $3.00B 113.83%
2015-11-30 $4.48B $2.92B 169.18%
2015-08-31 $4.22B $2.58B 64.71%
2015-05-31 $4.00B $3.34B 39.43%
2015-02-28 $3.41B $1.76B 24.22%
2014-11-30 $2.09B $18.41B 11.44%
2014-08-31 $1.93B $17.08B 10.71%
2014-05-31 $2.88B $19.12B 15.98%
2014-02-28 $2.79B $18.38B 16.04%
2013-11-30 $2.83B $17.57B 16.70%
2013-08-31 $2.55B $17.04B 15.40%
2013-05-31 $2.15B $16.58B 13.16%
2013-02-28 $2.06B $16.59B 13.39%
2012-11-30 $1.99B $15.98B 13.78%
2012-08-31 $2.13B $16.08B 15.66%
2012-05-31 $2.57B $12.87B 20.09%
2012-02-29 $2.63B $12.74B 20.62%
2011-11-30 $2.69B $12.66B 21.04%
2011-08-31 $2.71B $12.83B 21.33%
2011-05-31 $2.39B $12.83B 18.91%
2011-02-28 $2.25B $12.78B 17.67%
2010-11-30 $2.18B $12.47B 16.89%
2010-08-31 $2.09B $12.51B 15.98%
2010-05-31 $2.06B $13.22B 15.60%
2010-02-28 $2.12B $13.47B 16.20%
2009-11-30 $2.09B $13.15B 16.36%
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $8.179B $147.658B
Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $70.208B 7.47
Herbalife (HLF) Cayman Islands $0.789B 4.16
China Jo-Jo Drugstores Holdings (CJJD) China $0.016B 0.00
GNC Holdings (GNC) United States $0.000B 0.00